CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials

Rennie, 2001, CONSORT revised—improving the reporting of randomized trials, J Am Med Assoc, 285, 2006, 10.1001/jama.285.15.2006 Schulz, 1995, Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials, J Am Med Assoc, 273, 408, 10.1001/jama.1995.03520290060030 Moher, 1998, CONSORT: an evolving tool to help improve the quality of reports of randomized controlled trials. Consolidated Standards of Reporting Trials, J Am Med Assoc, 279, 1489, 10.1001/jama.279.18.1489 Kjaergard, 1999 Jüni, 2001, Systematic reviews in health care: assessing the quality of controlled clinical trials, Br Med J, 323, 42, 10.1136/bmj.323.7303.42 Veldhuyzen van Zanten, 1996, Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials, Am J Gastroenterol, 91, 660 Talley, 1996, Psychological treatments for irritable bowel syndrome: a critique of controlled treatment trials, Am J Gastroenterol, 91, 277 Adetugbo, 2000, How well are randomized controlled trials reported in the dermatology literature?, Arch Dermatol, 136, 381, 10.1001/archderm.136.3.381 Kjaergard, 1999, Randomized clinical trials in HEPATOLOGY: predictors of quality, Hepatology, 30, 1134, 10.1002/hep.510300510 Schor, 1966, Statistical evaluation of medical journal manuscripts, J Am Med Assoc, 195, 1123, 10.1001/jama.1966.03100130097026 Gore, 1977, Misuse of statistical methods: critical assessment of articles in BMJ from January to March 1976, Br Med J, 1, 85, 10.1136/bmj.1.6053.85 Hall, 1982, Misuse of statistical methods in the Australasian surgical literature, Aust N Z J Surg, 52, 541, 10.1111/j.1445-2197.1982.tb06050.x Altman, 1982, Statistics in medical journals, Stat Med, 1, 59, 10.1002/sim.4780010109 Pocock, 1987, Statistical problems in the reporting of clinical trials. A survey of three medical journals, N Engl J Med, 317, 426, 10.1056/NEJM198708133170706 Altman, 1994, The scandal of poor medical research, Br Med J, 308, 283, 10.1136/bmj.308.6924.283 Chan, 2005, Epidemiology and reporting of randomised trials published in PubMed journals, Lancet, 365, 1159, 10.1016/S0140-6736(05)71879-1 Hopewell, 2010, The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed, Br Med J, 340, c723, 10.1136/bmj.c723 Hollis, 1999, What is meant by intention to treat analysis? Survey of published randomised controlled trials, Br Med J, 319, 670, 10.1136/bmj.319.7211.670 Lai, 2007, Quality of reporting of key methodological items of randomized controlled trials in clinical ophthalmic journals, Ophthalmic Epidemiol, 14, 390, 10.1080/09286580701344399 Moher, 1996, Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews, Lancet, 347, 363, 10.1016/S0140-6736(96)90538-3 Junker, 1998, Adherence to published standards of reporting: a comparison of placebo-controlled trials published in English or German, J Am Med Assoc, 280, 247, 10.1001/jama.280.3.247 Altman, 1991, Randomisation, Br Med J, 302, 1481, 10.1136/bmj.302.6791.1481 Schulz, 1994, Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals, J Am Med Assoc, 272, 125, 10.1001/jama.1994.03520020051014 1948, Streptomycin treatment of pulmonary tuberculosis: a Medical Research Council investigation, Br Med J, 2, 769, 10.1136/bmj.2.4582.769 Schulz, 1998, Randomized controlled trials, Clin Obstet Gynecol, 41, 245, 10.1097/00003081-199806000-00005 Greenland, 1990, Randomization, statistics, and causal inference, Epidemiology, 1, 421, 10.1097/00001648-199011000-00003 Armitage, 1982, The role of randomization in clinical trials, Stat Med, 1, 345, 10.1002/sim.4780010412 Kleijnen, 1997, So what’s so special about randomisation, 93 Chalmers, 1997, Assembling comparison groups to assess the effects of health care, J R Soc Med, 90, 379, 10.1177/014107689709000706 Nicolucci, 1989, Quality, evolution, and clinical implications of randomized, controlled trials on the treatment of lung cancer. A lost opportunity for meta-analysis, J Am Med Assoc, 262, 2101, 10.1001/jama.1989.03430150069028 Ah-See, 1998, A qualitative assessment of randomized controlled trials in otolaryngology, J Laryngol Otol, 112, 460, 10.1017/S0022215100140770 Altman, 1990, Randomisation and baseline comparisons in clinical trials, Lancet, 335, 149, 10.1016/0140-6736(90)90014-V Thornley, 1998, Content and quality of 2000 controlled trials in schizophrenia over 50 years, Br Med J, 317, 1181, 10.1136/bmj.317.7167.1181 DerSimonian, 1982, Reporting on methods in clinical trials, N Engl J Med, 306, 1332, 10.1056/NEJM198206033062204 1994, A proposal for structured reporting of randomized controlled trials. The Standards of Reporting Trials Group, J Am Med Assoc, 272, 1926, 10.1001/jama.1994.03520240054041 1994, Call for comments on a proposal to improve reporting of clinical trials in the biomedical literature. Working Group on Recommendations for Reporting of Clinical Trials in the Biomedical Literature, Ann Intern Med, 121, 894, 10.7326/0003-4819-121-11-199412010-00015 Rennie, 1995, Reporting randomized controlled trials. An experiment and a call for responses from readers, J Am Med Assoc, 273, 1054, 10.1001/jama.1995.03520370096044 Begg, 1996, Improving the quality of reporting of randomized controlled trials: the CONSORT statement, J Am Med Assoc, 276, 637, 10.1001/jama.1996.03540080059030 Piaggio, 2006, Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement, J Am Med Assoc, 295, 1152, 10.1001/jama.295.10.1152 Campbell, 2004, CONSORT statement: extension to cluster randomised trials, Br Med J, 328, 702, 10.1136/bmj.328.7441.702 Zwarenstein, 2008, Improving the reporting of pragmatic trials: an extension of the CONSORT statement, Br Med J, 337, a2390, 10.1136/bmj.a2390 Ioannidis, 2004, Better reporting of harms in randomized trials: an extension of the CONSORT statement, Ann Intern Med, 141, 781, 10.7326/0003-4819-141-10-200411160-00009 Boutron, 2008, Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration, Ann Intern Med, 148, 295, 10.7326/0003-4819-148-4-200802190-00008 Gagnier, 2006, Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement, Ann Intern Med, 144, 364, 10.7326/0003-4819-144-5-200603070-00013 Hopewell, 2008, CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration, PLoS Med, 5, e20, 10.1371/journal.pmed.0050020 Siegel, 1996, Recommendations for reporting cost-effectiveness analyses. Panel on cost-effectiveness in health and medicine, J Am Med Assoc, 276, 1339, 10.1001/jama.1996.03540160061034 Drummond, 1996, Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party, Br Med J, 313, 275, 10.1136/bmj.313.7052.275 Lang, 1997 Davidoff, 2000, News from the International Committee of Medical Journal Editors, Ann Intern Med, 133, 229, 10.7326/0003-4819-133-3-200008010-00017 Plint, 2006, Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review, Med J Aust, 185, 263, 10.5694/j.1326-5377.2006.tb00557.x Egger, 2001, Value of flow diagrams in reports of randomized controlled trials, J Am Med Assoc, 285, 1996, 10.1001/jama.285.15.1996 Moher, 2001, The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials, Ann Intern Med, 134, 657, 10.7326/0003-4819-134-8-200104170-00011 Moher, 2001, The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials, J Am Med Assoc, 285, 1987, 10.1001/jama.285.15.1987 Moher, 2001, The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials, Lancet, 357, 1191, 10.1016/S0140-6736(00)04337-3 Chan, 2004, Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles, J Am Med Assoc, 291, 2457, 10.1001/jama.291.20.2457 Al-Marzouki, 2008, Selective reporting in clinical trials: analysis of trial protocols accepted by the Lancet, Lancet, 372, 201, 10.1016/S0140-6736(08)61060-0 Dwan, 2008, Systematic review of the empirical evidence of study publication bias and outcome reporting bias, PLoS ONE, 3, e3081, 10.1371/journal.pone.0003081 Altman, 2001, The revised CONSORT statement for reporting randomized trials: explanation and elaboration, Ann Intern Med, 134, 663, 10.7326/0003-4819-134-8-200104170-00012 Schulz, 2010, CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials, Br Med J, 340, c332, 10.1136/bmj.c332 Pocock, 1983 Meinert, 1986 Friedman, 1998 Bolliger, 2000, Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety, Br Med J, 321, 329, 10.1136/bmj.321.7257.329 Dickersin, 2002, Development of the Cochrane Collaboration’s CENTRAL Register of controlled clinical trials, Eval Health Prof, 25, 38, 10.1177/0163278702025001004 Hopewell, 2008, CONSORT for reporting randomised trials in journal and conference abstracts, Lancet, 371, 281, 10.1016/S0140-6736(07)61835-2 2006, The impact of open access upon public health, PLoS Med, 3, e252, 10.1371/journal.pmed.0030252 Harbourt, 1995, Structured abstracts in MEDLINE, 1989–1991, Bull Med Libr Assoc, 83, 190 Harris, 2002, The accuracy of abstracts in psychology journals, J Psychol, 136, 141 Pitkin, 1999, Accuracy of data in abstracts of published research articles, J Am Med Assoc, 281, 1110, 10.1001/jama.281.12.1110 Ward, 2004, Accuracy of abstracts for original research articles in pharmacy journals, Ann Pharmacother, 38, 1173, 10.1345/aph.1D416 Gøtzsche, 2006, Believability of relative risks and odds ratios in abstracts: cross sectional study, Br Med J, 333, 231, 10.1136/bmj.38895.410451.79 Ioannidis, 2001, Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas, J Am Med Assoc, 285, 437, 10.1001/jama.285.4.437 Haynes, 1990, More informative abstracts revisited, Ann Intern Med, 113, 69, 10.7326/0003-4819-113-1-69 Taddio, 1994, Quality of nonstructured and structured abstracts of original research articles in the British Medical Journal, the Canadian Medical Association Journal and the Journal of the American Medical Association, CMAJ, 150, 1611 Wager, 2008, Technical editing of research reports in biomedical journals, Cochrane Database Syst Rev, 10.1002/14651858.MR000002.pub3 Hartley, 1996, Obtaining information accurately and quickly: are structured abstracts more efficient?, J Inform Sci, 22, 349, 10.1177/016555159602200503 Gilligan, 2007, Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review, Lancet, 369, 1929, 10.1016/S0140-6736(07)60714-4 Sandler, 1999, Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder, N Engl J Med, 341, 1801, 10.1056/NEJM199912093412404 World Medical Association, 2008 Lau, 1992, Cumulative meta-analysis of therapeutic trials for myocardial infarction, N Engl J Med, 327, 248, 10.1056/NEJM199207233270406 Fergusson, 2005, Randomized controlled trials of aprotinin in cardiac surgery: could clinical equipoise have stopped the bleeding?, Clin Trials, 2, 218, 10.1191/1740774505cn085oa Savulescu, 1996, Are research ethics committees behaving unethically? Some suggestions for improving performance and accountability, Br Med J, 313, 1390, 10.1136/bmj.313.7069.1390 Sadler, 2000, A randomised controlled trial and meta-analysis of active management of labour, BJOG, 107, 909, 10.1111/j.1471-0528.2000.tb11091.x Bath, 1998, Quality of full and final publications reporting acute stroke trials: a systematic review, Stroke, 29, 2203, 10.1161/01.STR.29.10.2203 Blumer, 2009, Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention-deficit/hyperactivity disorder in children 6 to 17 years of age, Pediatrics, 123, e770, 10.1542/peds.2008-2945 Sabatine, 2009, Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial, Lancet, 374, 787, 10.1016/S0140-6736(09)61454-9 Grant, 2005, Issues in data monitoring and interim analysis of trials, Health Technol Assess, 9, 1, 10.3310/hta9070 Gallo, 2006, PhRMA Working Group on adaptive designs, “White Paper”, Drug Inf J, 40, 421, 10.1177/216847900604000407 Brown, 2009, Adaptive designs for randomized trials in public health, Annu Rev Public Health, 30, 1, 10.1146/annurev.publhealth.031308.100223 Kelly, 2005, A practical comparison of group-sequential and adaptive designs, J Biopharm Stat, 15, 719, 10.1081/BIP-200062859 Pildal, 2005, Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study, Br Med J, 330, 1049, 10.1136/bmj.38414.422650.8F Chan, 2008, Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols, Br Med J, 337, a2299, 10.1136/bmj.a2299 Ndekha, 2009, Supplementary feeding with either ready-to-use fortified spread or corn-soy blend in wasted adults starting antiretroviral therapy in Malawi: randomised, investigator blinded, controlled trial, Br Med J, 338, 1867, 10.1136/bmj.b1867 Rothwell, 2005, External validity of randomised controlled trials: "to whom do the results of this trial apply?", Lancet, 365, 82, 10.1016/S0140-6736(04)17670-8 Fuks, 1998, A study in contrasts: eligibility criteria in a twenty-year sample of NSABP and POG clinical trials. National Surgical Adjuvant Breast and Bowel Program. Pediatric Oncology Group, J Clin Epidemiol, 51, 69, 10.1016/S0895-4356(97)00240-0 Shapiro, 2000, Reporting the study populations of clinical trials. Clear transmission or static on the line?, J Clin Epidemiol, 53, 973, 10.1016/S0895-4356(00)00227-4 Gandhi, 2005, Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols, AIDS, 19, 1885, 10.1097/01.aids.0000189866.67182.f7 Hall, 1996, Methodologic standards in surgical trials, Surgery, 119, 466, 10.1016/S0039-6060(96)80149-8 Weiss, 2008, Generalizability of the results of randomized trials, Arch Intern Med, 168, 133, 10.1001/archinternmed.2007.30 Devereaux, 2008, Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial, Lancet, 371, 1839, 10.1016/S0140-6736(08)60601-7 Rannou, 2009, Splint for base-of-thumb osteoarthritis: a randomized trial, Ann Intern Med, 150, 661, 10.7326/0003-4819-150-10-200905190-00003 Glasziou, 2008, What is missing from descriptions of treatment in trials and reviews?, Br Med J, 336, 1472, 10.1136/bmj.39590.732037.47 Mease, 2000, Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial, Lancet, 356, 385, 10.1016/S0140-6736(00)02530-7 McDowell, 2006 Streiner, 2003 Clarke, 2007, Standardising outcomes for clinical trials and systematic reviews, Trials, 8, 39, 10.1186/1745-6215-8-39 Sanders, 1998, Reporting on quality of life in randomised controlled trials: bibliographic study, Br Med J, 317, 1191, 10.1136/bmj.317.7167.1191 Gøtzsche, 1989, Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis, Control Clin Trials, 10, 31, 10.1016/0197-2456(89)90017-2 Marshall, 2000, Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia, Br J Psychiatry, 176, 249, 10.1192/bjp.176.3.249 Jadad, 1999 Schachter, 2000 Dargie, 2001, Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial, Lancet, 357, 1385, 10.1016/S0140-6736(00)04560-8 Chan, 2004, Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research, CMAJ, 171, 735, 10.1503/cmaj.1041086 Vermeulen, 2009, Intravenous fluid restriction after major abdominal surgery: a randomized blinded clinical trial, Trials, 10, 50, 10.1186/1745-6215-10-50 Fox, 2008, Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial, Lancet, 372, 807, 10.1016/S0140-6736(08)61170-8 Campbell, 1995, Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons, Br Med J, 311, 1145, 10.1136/bmj.311.7013.1145 Guyatt, 2008, In the era of systematic reviews, does the size of an individual trial still matter, PLoS Med, 5, e4, 10.1371/journal.pmed.0050004 Schulz, 2005, Sample size calculations in randomised trials: mandatory and mystical, Lancet, 365, 1348, 10.1016/S0140-6736(05)61034-3 Halpern, 2002, The continuing unethical conduct of underpowered clinical trials, J Am Med Assoc, 288, 358, 10.1001/jama.288.3.358 Altman, 1995, Absence of evidence is not evidence of absence, Br Med J, 311, 485, 10.1136/bmj.311.7003.485 Moher, 1994, Statistical power, sample size, and their reporting in randomized controlled trials, J Am Med Assoc, 272, 122, 10.1001/jama.1994.03520020048013 Freiman, 1978, The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials, N Engl J Med, 299, 690, 10.1056/NEJM197809282991304 Charles, 2009, Reporting of sample size calculation in randomised controlled trials: review, Br Med J, 338, b1732, 10.1136/bmj.b1732 Yusuf, 1984, Why do we need some large, simple randomized trials?, Stat Med, 3, 409, 10.1002/sim.4780030421 Goodman, 1994, The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results, Ann Intern Med, 121, 200, 10.7326/0003-4819-121-3-199408010-00008 Galgiani, 2000, Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group, Ann Intern Med, 133, 676, 10.7326/0003-4819-133-9-200011070-00009 Connolly, 2009, Effect of clopidogrel added to aspirin in patients with atrial fibrillation, N Engl J Med, 360, 2066, 10.1056/NEJMoa0901301 Geller, 1987, Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners, Biometrics, 43, 213, 10.2307/2531962 Berry, 1985, Interim analyses in clinical trials: classical vs. Bayesian approaches, Stat Med, 4, 521, 10.1002/sim.4780040412 Pocock, 1992, When to stop a clinical trial, Br Med J, 305, 235, 10.1136/bmj.305.6847.235 DeMets, 1999, The agonising negative trend in monitoring of clinical trials, Lancet, 354, 1983, 10.1016/S0140-6736(99)03464-9 Buyse, 1993, Interim analyses, stopping rules and data monitoring in clinical trials in Europe, Stat Med, 12, 509, 10.1002/sim.4780120517 Sydes, 2004, Reported use of data monitoring committees in the main published reports of randomized controlled trials: a cross-sectional study, Clin Trials, 1, 48, 10.1191/1740774504cn003oa Montori, 2005, Randomized trials stopped early for benefit: a systematic review, J Am Med Assoc, 294, 2203, 10.1001/jama.294.17.2203 Coutinho, 2008, Uterine exteriorization compared with in situ repair at cesarean delivery: a randomized controlled trial, Obstet Gynecol, 111, 639, 10.1097/AOG.0b013e31816521e2 Jüni, 2001, Assessing the quality of controlled clinical trials Creinin, 2008, Multicenter comparison of the contraceptive ring and patch: a randomized controlled trial, Obstet Gynecol, 111, 267, 10.1097/01.AOG.0000298338.58511.d1 Tate, 2003, Effects of internet behavioral counseling on weight loss in adults at risk for type 2 diabetes: a randomized trial, J Am Med Assoc, 289, 1833, 10.1001/jama.289.14.1833 Lachin, 1988, Properties of simple randomization in clinical trials, Control Clin Trials, 9, 312, 10.1016/0197-2456(88)90046-3 Peto, 1976, Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design, Br J Cancer, 34, 585, 10.1038/bjc.1976.220 Schulz, 2006 Altman, 1999, How to randomise, Br Med J, 319, 703, 10.1136/bmj.319.7211.703 Schulz, 1995, Subverting randomization in controlled trials, J Am Med Assoc, 274, 1456, 10.1001/jama.1995.03530180050029 Enas, 1990, Baseline comparability in clinical trials: prevention of poststudy anxiety, Drug Inf J, 24, 541, 10.1177/009286159002400312 Treasure, 1998, Minimisation: the platinum standard for trials? Randomisation doesn’t guarantee similarity of groups; minimisation does, Br Med J, 317, 362, 10.1136/bmj.317.7155.362 Sinei, 1990, Preventing IUCD-related pelvic infection: the efficacy of prophylactic doxycycline at insertion, Br J Obstet Gynaecol, 97, 412, 10.1111/j.1471-0528.1990.tb01828.x Radford, 2006, Effectiveness of low-Dye taping for the short-term treatment of plantar heel pain: a randomised trial, BMC Musculoskelet Disord, 7, 64, 10.1186/1471-2474-7-64 Chalmers, 1987, Meta-analysis of clinical trials as a scientific discipline. I: control of bias and comparison with large co-operative trials, Stat Med, 6, 315, 10.1002/sim.4780060320 Pocock, 1982, Statistical aspects of clinical trial design, Statistician, 31, 1, 10.2307/2988097 Haag, 1998, Technologies for automating randomized treatment assignment in clinical trials, Drug Inf J, 32, 11, 10.1177/009286159803200102 Piaggio, 2003, The reporting of methods for reducing and detecting bias: an example from the WHO Misoprostol Third Stage of Labour equivalence randomised controlled trial, BMC Med Res Methodol, 3, 19, 10.1186/1471-2288-3-19 Pildal, 2007, Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials, Int J Epidemiol, 36, 847, 10.1093/ije/dym087 Wood, 2008, Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study, Br Med J, 336, 601, 10.1136/bmj.39465.451748.AD McCandlish, 1998, A randomised controlled trial of care of the perineum during second stage of normal labour, Br J Obstet Gynaecol, 105, 1262, 10.1111/j.1471-0528.1998.tb10004.x Webster, 2008, Routine care of peripheral intravenous catheters versus clinically indicated replacement: randomised controlled trial, Br Med J, 337, a339, 10.1136/bmj.a339 Smith, 2008, Chronic care model and shared care in diabetes: randomized trial of an electronic decision support system, Mayo Clin Proc, 83, 747, 10.4065/83.7.747 Sacks, 2009, Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates, N Engl J Med, 360, 859, 10.1056/NEJMoa0804748 Kaptchuk, 1998, Intentional ignorance: a history of blind assessment and placebo controls in medicine, Bull Hist Med, 72, 389, 10.1353/bhm.1998.0159 Guyatt, 1984, Effect of encouragement on walking test performance, Thorax, 39, 818, 10.1136/thx.39.11.818 Gøtzsche, 1996, Blinding during data analysis and writing of manuscripts, Control Clin Trials, 17, 285, 10.1016/0197-2456(95)00263-4 Karlowski, 1975, Ascorbic acid for the common cold. A prophylactic and therapeutic trial, J Am Med Assoc, 231, 1038, 10.1001/jama.1975.03240220018013 Noseworthy, 1994, The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial, Neurology, 44, 16, 10.1212/WNL.44.1.16 Carley, 2000, An open prospective randomised trial to reduce the pain of blood glucose testing: ear versus thumb, Br Med J, 321, 20, 10.1136/bmj.321.7252.20 Schulz, 2002, The landscape and lexicon of blinding in randomized trials, Ann Intern Med, 136, 254, 10.7326/0003-4819-136-3-200202050-00022 Day, 2000, Statistics notes: blinding in clinical trials and other studies, Br Med J, 321, 504, 10.1136/bmj.321.7259.504 Montori, 2002, In the dark: the reporting of blinding status in randomized controlled trials, J Clin Epidemiol, 55, 787, 10.1016/S0895-4356(02)00446-8 Cheng, 2000, Randomized controlled trials in cystic fibrosis (1966–1997) categorized by time, design, and intervention, Pediatr Pulmonol, 29, 1, 10.1002/(SICI)1099-0496(200001)29:1<1::AID-PPUL1>3.0.CO;2-1 Lang, 2000, Masking or blinding? An unscientific survey of mostly medical journal editors on the great debate, Med Gen Med, 2, E25 Devereaux, 2001, Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials, J Am Med Assoc, 285, 2000, 10.1001/jama.285.15.2000 Haahr, 2006, Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors, Clin Trials, 3, 360, 10.1177/1740774506069153 Meinert, 1998, Masked monitoring in clinical trials—blind stupidity?, N Engl J Med, 338, 1381, 10.1056/NEJM199805073381911 Mills, 2003, The safety of over-the-counter niacin. A randomized placebo-controlled trial [ISRCTN18054903], BMC Clin Pharmacol, 3, 4, 10.1186/1472-6904-3-4 Schulz, 1996, Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology, Br Med J, 312, 742, 10.1136/bmj.312.7033.742 Fergusson, 2004, Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials, Br Med J, 328, 432, 10.1136/bmj.37952.631667.EE Sackett, 2004, Turning a blind eye: why we don’t test for blindness at the end of our trials, Br Med J, 328, 1136, 10.1136/bmj.328.7448.1136-a Astrup, 2009, Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study, Lancet, 374, 1606, 10.1016/S0140-6736(09)61375-1 Altman, 2000, Statistical guidelines for contributors to medical journals, 171 Altman, 1997, Statistics notes. Units of analysis, Br Med J, 314, 1874, 10.1136/bmj.314.7098.1874 Bolton, 1998, Independence and statistical inference in clinical trial designs: a tutorial review, J Clin Pharmacol, 38, 408, 10.1002/j.1552-4604.1998.tb04444.x Greenland, 2000, Principles of multilevel modelling, Int J Epidemiol, 29, 158, 10.1093/ije/29.1.158 Albert, 2008, Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial, J Am Med Assoc, 299, 2027, 10.1001/jama.299.17.2027 Matthews, 1996, Interaction 3: how to examine heterogeneity, Br Med J, 313, 862, 10.1136/bmj.313.7061.862 Assmann, 2000, Subgroup analysis and other (mis)uses of baseline data in clinical trials, Lancet, 355, 1064, 10.1016/S0140-6736(00)02039-0 Matthews, 1996, Statistics notes. Interaction 2: compare effect sizes not P values, Br Med J, 313, 808, 10.1136/bmj.313.7060.808 Oxman, 1992, A consumer’s guide to subgroup analyses, Ann Intern Med, 116, 78, 10.7326/0003-4819-116-1-78 Steyerberg, 2000, Clinical trials in acute myocardial infarction: should we adjust for baseline characteristics?, Am Heart J, 139, 745, 10.1016/S0002-8703(00)90001-2 Altman, 1998, Adjustment for covariate imbalance, 1000 Mullner, 2002, Reporting on statistical methods to adjust for confounding: a cross-sectional survey, Ann Intern Med, 136, 122, 10.7326/0003-4819-136-2-200201150-00009 Concato, 1993, The risk of determining risk with multivariable models, Ann Intern Med, 118, 201, 10.7326/0003-4819-118-3-199302010-00009 Bender, 1996, Logistic regression models used in medical research are poorly presented, Br Med J, 313, 628, 10.1136/bmj.313.7057.628 Khan, 1999, Logistic regression models in obstetrics and gynecology literature, Obstet Gynecol, 93, 1014 Sackett, 1979, Controversy in counting and attributing events in clinical trials, N Engl J Med, 301, 1410, 10.1056/NEJM197912273012602 May, 1981, The randomized clinical trial: bias in analysis, Circulation, 64, 669, 10.1161/01.CIR.64.4.669 Altman, 1994, More on zidovudine in asymptomatic HIV infection, N Engl J Med, 330, 1758, 10.1056/NEJM199406163302415 Meinert, 1998, Beyond CONSORT: need for improved reporting standards for clinical trials. Consolidated Standards of Reporting Trials, J Am Med Assoc, 279, 1487, 10.1001/jama.279.18.1487 Grant, 2008, Minimal access surgery compared with medical management for chronic gastro-oesophageal reflux disease: UK collaborative randomised trial, Br Med J, 337, a2664, 10.1136/bmj.a2664 van Loon, 1997, Randomised controlled trial of magnetic-resonance pelvimetry in breech presentation at term, Lancet, 350, 1799, 10.1016/S0140-6736(97)05431-7 Brown, 2000, Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT), Lancet, 356, 366, 10.1016/S0140-6736(00)02527-7 LaCroix, 2000, Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults. A randomized, double-blind, placebo-controlled trial, Ann Intern Med, 133, 516, 10.7326/0003-4819-133-7-200010030-00010 Shuster, 1991, Median follow-up in clinical trials, J Clin Oncol, 9, 191, 10.1200/JCO.1991.9.1.191 Altman, 1995, Review of survival analyses published in cancer journals, Br J Cancer, 72, 511, 10.1038/bjc.1995.364 Auvert, 2005, Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265, Trial PLoS Med, 2, e298, 10.1371/journal.pmed.0020298 Diggle, 2000, Effect of needle length on incidence of local reactions to routine immunisation in infants aged 4 months: randomised controlled trial, Br Med J, 321, 931, 10.1136/bmj.321.7266.931 Pocock, 1999, Trials stopped early: too good to be true?, Lancet, 353, 943, 10.1016/S0140-6736(98)00379-1 Hughes, 1988, Stopping rules and estimation problems in clinical trials, Stat Med, 7, 1231, 10.1002/sim.4780071204 Kiri, 2004, Treatment effects monitoring committees and early stopping in large clinical trials, Clin Trials, 1, 40, 10.1191/1740774504cn014oa Psaty, 2003, Stopping medical research to save money: a broken pact with researchers and patients, J Am Med Assoc, 289, 2128, 10.1001/jama.289.16.2128 Temple, 2006, FDA perspective on trials with interim efficacy evaluations, Stat Med, 25, 3245, 10.1002/sim.2631 Yusuf, 2008, Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial, Lancet, 372, 1174, 10.1016/S0140-6736(08)61242-8 Senn, 1995, Base logic: tests of baseline balance in randomized clinical trials, Clin Res Regul Aff, 12, 171, 10.3109/10601339509019426 Altman, 1985, Comparability of randomised groups, Statistician, 34, 125, 10.2307/2987510 Heit, 2000, Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip or knee replacement. A randomized, double-blind, placebo-controlled trial, Ann Intern Med, 132, 853, 10.7326/0003-4819-132-11-200006060-00002 Haderslev, 2000, Alendronate increases lumbar spine bone mineral density in patients with Crohn’s disease, Gastroenterology, 119, 639, 10.1053/gast.2000.16518 Fields, 1970, Joint study of extracranial arterial occlusion. V. Progress report of prognosis following surgery or nonsurgical treatment for transient cerebral ischemic attacks and cervical carotid artery lesions, J Am Med Assoc, 211, 1993, 10.1001/jama.1970.03170120039008 Lee, 1991, Analysis of clinical trials by treatment actually received: is it really an option?, Stat Med, 10, 1595, 10.1002/sim.4780101011 Lewis, 1993, Intention to treat—who should use ITT?, Br J Cancer, 68, 647, 10.1038/bjc.1993.402 Lachin, 2000, Statistical considerations in the intent-to-treat principle, Control Clin Trials, 21, 526, 10.1016/S0197-2456(00)00092-1 Sheiner, 1995, Intention-to-treat analysis and the goals of clinical trials, Clin Pharmacol Ther, 57, 6, 10.1016/0009-9236(95)90260-0 Nagelkerke, 2000, Estimating treatment effects in randomized clinical trials in the presence of non-compliance, Stat Med, 19, 1849, 10.1002/1097-0258(20000730)19:14<1849::AID-SIM506>3.0.CO;2-1 Melander, 2003, Evidence b(i)ased medicine–selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications, Br Med J, 326, 1171, 10.1136/bmj.326.7400.1171 Gravel, 2007, The intention-to-treat approach in randomized controlled trials: are authors saying what they do and doing what they say?, Clin Trials, 4, 350, 10.1177/1740774507081223 Kruse, 2002, Intention-to-treat analysis: who is in? Who is out?, J Fam Pract, 51, 969 Herman, 2009, Intention-to-treat analysis and accounting for missing data in orthopaedic randomized clinical trials, J Bone Jt Surg Am, 91, 2137, 10.2106/JBJS.H.01481 Ruiz-Canela, 2000, Intention to treat analysis is related to methodological quality, Br Med J, 320, 1007, 10.1136/bmj.320.7240.1007 Altman, 2009, Missing outcomes in randomised trials: addressing the dilemma, Open Med, 3, e21 Wood, 2004, Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals, Clin Trials, 1, 368, 10.1191/1740774504cn032oa Streiner, 2008, Missing data and the trouble with LOCF, Evid Based Ment Health, 11, 3, 10.1136/ebmh.11.1.3-a Molnar, 2008, Does analysis using "last observation carried forward" introduce bias in dementia research?, CMAJ, 179, 751, 10.1503/cmaj.080820 Ware, 2003, Interpreting incomplete data in studies of diet and weight loss, N Engl J Med, 348, 2136, 10.1056/NEJMe030054 Streiner, 2002, The case of the missing data: methods of dealing with dropouts and other research vagaries, Can J Psychiatry, 47, 68, 10.1177/070674370204700111 Lane, 2008, Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches, Pharm Stat, 7, 93, 10.1002/pst.267 Abraha, 2007 Altman, 2000, Confidence intervals in practice, 6 van Linschoten, 2009, Supervised exercise therapy versus usual care for patellofemoral pain syndrome: an open label randomised controlled trial, Br Med J, 339, b4074, 10.1136/bmj.b4074 Altman, 2000, Clinical trials and meta-analyses, 120 1997, Uniform requirements for manuscripts submitted to biomedical journals. International Committee of Medical Journal Editors, Ann Intern Med, 126, 36, 10.7326/0003-4819-126-1-199701010-00006 Gardner, 1986, Confidence intervals rather than P values: estimation rather than hypothesis testing, Br Med J, 292, 746, 10.1136/bmj.292.6522.746 Bailar, 1988, Guidelines for statistical reporting in articles for medical journals. Amplifications and explanations, Ann Intern Med, 108, 266, 10.7326/0003-4819-108-2-266 Bland, 1997, Quoting intermediate analyses can only mislead, Br Med J, 314, 1907, 10.1136/bmj.314.7098.1907a Cook, 1995, The number needed to treat: a clinically useful measure of treatment effect, Br Med J, 310, 452, 10.1136/bmj.310.6977.452 Altman, 1999, Calculating the number needed to treat for trials where the outcome is time to an event, Br Med J, 319, 1492, 10.1136/bmj.319.7223.1492 1992, Early versus delayed neonatal administration of a synthetic surfactant—the judgment of OSIRIS (open study of infants at high risk of or with respiratory insufficiency—the role of surfactant), Lancet, 340, 1363, 10.1016/0140-6736(92)92557-V Sorensen, 2008, Laypersons’ understanding of relative risk reductions: randomised cross-sectional study, BMC Med Inform Decis Mak, 8, 31, 10.1186/1472-6947-8-31 Bobbio, 1994, Completeness of reporting trial results: effect on physicians’ willingness to prescribe, Lancet, 343, 1209, 10.1016/S0140-6736(94)92407-4 Naylor, 1992, Measured enthusiasm: does the method of reporting trial results alter perceptions of therapeutic effectiveness?, Ann Intern Med, 117, 916, 10.7326/0003-4819-117-11-916 Tukey, 1977, Some thoughts on clinical trials, especially problems of multiplicity, Science, 198, 679, 10.1126/science.333584 Yusuf, 1991, Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials, J Am Med Assoc, 266, 93, 10.1001/jama.1991.03470010097038 Hahn, 2000, Assessing the potential for bias in meta-analysis due to selective reporting of subgroup analyses within studies, Stat Med, 19, 3325, 10.1002/1097-0258(20001230)19:24<3325::AID-SIM827>3.0.CO;2-D Bhandari, 2006, Misuse of baseline comparison tests and subgroup analyses in surgical trials, Clin Orthop Relat Res, 447, 247, 10.1097/01.blo.0000218736.23506.fe Levin, 2000, Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group, Lancet, 356, 961, 10.1016/S0140-6736(00)02712-4 Scharf, 2006, Adverse event reporting in publications compared with sponsor database for cancer clinical trials, J Clin Oncol, 24, 3933, 10.1200/JCO.2005.05.3959 Pitrou, 2009, Reporting of safety results in published reports of randomized controlled trials, Arch Intern Med, 169, 1756, 10.1001/archinternmed.2009.306 Boden, 2007, Optimal medical therapy with or without PCI for stable coronary disease, N Engl J Med, 356, 1503, 10.1056/NEJMoa070829 Horton, 1995, The rhetoric of research, Br Med J, 310, 985, 10.1136/bmj.310.6985.985 Annals of Internal Medicine, 2008 Docherty, 1999, The case for structuring the discussion of scientific papers, Br Med J, 318, 1224, 10.1136/bmj.318.7193.1224 Purcell, 1998, Changes to manuscripts during the editorial process: characterizing the evolution of a clinical paper, J Am Med Assoc, 280, 227, 10.1001/jama.280.3.227 Ioannidis, 2007, Limitations are not properly acknowledged in the scientific literature, J Clin Epidemiol, 60, 324, 10.1016/j.jclinepi.2006.09.011 Kiviluoto, 1998, Randomised trial of laparoscopic versus open cholecystectomy for acute and gangrenous cholecystitis, Lancet, 351, 321, 10.1016/S0140-6736(97)08447-X Hupperets, 2009, Effect of unsupervised home based proprioceptive training on recurrences of ankle sprain: randomised controlled trial, Br Med J, 339, b2684, 10.1136/bmj.b2684 Garber, 2009, Prevention of depression in at-risk adolescents: a randomized controlled trial, J Am Med Assoc, 301, 2215, 10.1001/jama.2009.788 Campbell, 1957, Factors relevant to the validity of experiments in social settings, Psychol Bull, 54, 297, 10.1037/h0040950 Rothwell, 2006, Factors that can affect the external validity of randomised controlled trials, PLoS Clin Trials, 1, e9, 10.1371/journal.pctr.0010009 King, 2005, Conceptual framework and systematic review of the effects of participants’ and professionals’ preferences in randomised controlled trials, Health Technol Assess, 9, 1, 10.3310/hta9350 Djulbegovic, 2000, The uncertainty principle and industry-sponsored research, Lancet, 356, 635, 10.1016/S0140-6736(00)02605-2 Dans, 1998, Users’ guides to the medical literature: XIV. How to decide on the applicability of clinical trial results to your patient. Evidence-Based Medicine Working Group, J Am Med Assoc, 279, 545, 10.1001/jama.279.7.545 Smith, 1994, Who benefits from medical interventions?, Br Med J, 308, 72, 10.1136/bmj.308.6921.72 McAlister, 2001, Applying the results of systematic reviews at the bedside Bartlett, 2005, The causes and effects of socio-demographic exclusions from clinical trials, Health Technol Assess, 9, 1 Bonell, 2006, Assessment of generalisability in trials of health interventions: suggested framework and systematic review, Br Med J, 333, 346, 10.1136/bmj.333.7563.346 Bornhöft, 2006, Checklist for the qualitative evaluation of clinical studies with particular focus on external validity and model validity, BMC Med Res Methodol, 6, 56, 10.1186/1471-2288-6-56 Laupacis, 1988, An assessment of clinically useful measures of the consequences of treatment, N Engl J Med, 318, 1728, 10.1056/NEJM198806303182605 Altman, 1998, Confidence intervals for the number needed to treat, Br Med J, 317, 1309, 10.1136/bmj.317.7168.1309 Fanaroff, 1994, A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network, N Engl J Med, 330, 1107, 10.1056/NEJM199404213301602 1986, Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group, Lancet, 2, 57 Gøtzsche, 1995, Somatostatin v placebo in bleeding oesophageal varices: randomised trial and meta-analysis, Br Med J, 310, 1495, 10.1136/bmj.310.6993.1495 Clarke, 2007, Reports of clinical trials should begin and end with up-to-date systematic reviews of other relevant evidence: a status report, J R Soc Med, 100, 187, 10.1258/jrsm.100.4.187 Goodman, 1999, Toward evidence-based medical statistics. 1: the P value fallacy, Ann Intern Med, 130, 995, 10.7326/0003-4819-130-12-199906150-00008 Gøtzsche, 1987, Reference bias in reports of drug trials, Br Med J, 295, 654, 10.1136/bmj.295.6599.654 Papp, 2008, Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study, Lancet, 371, 1337, 10.1016/S0140-6736(08)60593-0 Dickersin, 1997, How important is publication bias? A synthesis of available data, AIDS Educ Prev, 9, 15 Song, 2000, Publication and related biases, Health Technol Assess, 4, 1, 10.3310/hta4100 Williamson, 2005, Identification and impact of outcome selection bias in meta-analysis, Stat Med, 24, 1547, 10.1002/sim.2025 Tramèr, 1997, Impact of covert duplicate publication on meta-analysis: a case study, Br Med J, 315, 635, 10.1136/bmj.315.7109.635 Simes, 1986, Publication bias: the case for an international registry of clinical trials, J Clin Oncol, 4, 1529, 10.1200/JCO.1986.4.10.1529 Chalmers, 2006, From optimism to disillusion about commitment to transparency in the medico-industrial complex, J R Soc Med, 99, 337, 10.1258/jrsm.99.7.337 Tonks, 2002, A clinical trials register for Europe, Br Med J, 325, 1314, 10.1136/bmj.325.7376.1314 Dickersin, 2003, Registering clinical trials, J Am Med Assoc, 290, 516, 10.1001/jama.290.4.516 Whittington, 2004, Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data, Lancet, 363, 1341, 10.1016/S0140-6736(04)16043-1 De Angelis, 2005, Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors, Lancet, 365, 1827, 10.1016/S0140-6736(05)66588-9 Zarin, 2007, Issues in the registration of clinical trials, J Am Med Assoc, 297, 2112, 10.1001/jama.297.19.2112 Hopewell, 2008, Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal ‘instructions to authors, Trials, 9, 20, 10.1186/1745-6215-9-20 Russell, 2008, Vasopressin versus norepinephrine infusion in patients with septic shock, N Engl J Med, 358, 877, 10.1056/NEJMoa067373 Chan, 2008, The SPIRIT initiative: defining standard protocol items for randomised trials. Oral presentation at the 16th Cochrane Colloquium: evidence in the era of globalisation; 2008 Oct 3–7; Freiburg, Germany, Z Evidenz, Fortbildung Qualitat im Gesundheitswesen, 102, 27 Gregson, 2007, Impact and process evaluation of integrated community and clinic-based HIV-1 control: a cluster-randomised trial in eastern Zimbabwe, PLoS Med, 4, e102, 10.1371/journal.pmed.0040102 Shaddy, 2007, Carvedilol for children and adolescents with heart failure: a randomized controlled trial, J Am Med Assoc, 298, 1171, 10.1001/jama.298.10.1171 Lexchin, 2003, Pharmaceutical industry sponsorship and research outcome and quality: systematic review, Br Med J, 326, 1167, 10.1136/bmj.326.7400.1167 Kjaergard, 2002, Association between competing interests and authors’ conclusions: epidemiological study of randomised clinical trials published in the BMJ, Br Med J, 325, 249, 10.1136/bmj.325.7358.249 Bero, 2007, Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others, PLoS Med, 4, e184, 10.1371/journal.pmed.0040184 Sismondo, 2008, Pharmaceutical company funding and its consequences: a qualitative systematic review, Contemp Clin Trials, 29, 109, 10.1016/j.cct.2007.08.001 Als-Nielsen, 2003, Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?, J Am Med Assoc, 290, 921, 10.1001/jama.290.7.921 Ross, 2008, Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation, J Am Med Assoc, 299, 1800, 10.1001/jama.299.15.1800 McAlister, 2003, Analysis and reporting of factorial trials: a systematic review, J Am Med Assoc, 289, 2545, 10.1001/jama.289.19.2545 Senn, 2002 Deeks, 2003, Evaluating non-randomised intervention studies, Health Technol Assess, 7, 173 Kunz, 2007, Randomisation to protect against selection bias in healthcare trials, Cochrane Database Syst Rev, 10.1002/14651858.MR000012.pub2 Collins, 2001, Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials, Lancet, 357, 373, 10.1016/S0140-6736(00)03651-5 Schulz, 1996, Randomised trials, human nature, and reporting guidelines, Lancet, 348, 596, 10.1016/S0140-6736(96)01201-9 Murray, 2000, Promoting good research practice, Stat Methods Med Res, 9, 17, 10.1191/096228000670253839 Narahari, 2008, Evidence-based approaches for the Ayurvedic traditional herbal formulations: toward an Ayurvedic CONSORT model, J Altern Complement Med, 14, 769, 10.1089/acm.2007.0818 Bossuyt, 2003, Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD Initiative, Ann Intern Med, 138, 40, 10.7326/0003-4819-138-1-200301070-00010 von Elm, 2007, The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies, Ann Intern Med, 147, 573, 10.7326/0003-4819-147-8-200710160-00010 Tonino, 2009, Fractional flow reserve versus angiography for guiding percutaneous coronary intervention, N Engl J Med, 360, 213, 10.1056/NEJMoa0807611